Anticonvulsant activity of a novel NMDA/glycine site antagonist, MDL 104,653, against kindled and sound-induced seizures.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  European Journal of Pharmacology

• Publication date

  1995-02-14

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0014-2999(94)00713-HPMID 7768284
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of NMDA- and strychnine-insensitive glycine site antagonists on NMDA-mediated convulsions and learning

  2005cited by this paper
• Antiepileptogenic and Anticonvulsant Effects of YM90K, a Selective AMPA‐Receptor Antagonist, in the Rat Kindling Model of Epilepsy

  1998cited by this paper
• Antiepileptogenic and anticonvulsant effects of NBQX, a selective AMPA receptor antagonist, in the rat kindling model of epilepsy.

  1994cited by this paper
• The effect of the non-NMDA receptor antagonist GYKI 52466 and NBQX and the competitive NMDA receptor antagonist D-CPPene on the development of amygdala kindling and on amygdala-kindled seizures.

  1994cited by this paper
• 3'-(Arylmethyl)- and 3'-(aryloxy)-3-phenyl-4-hydroxyquinolin-2(1H)-ones: orally active antagonists of the glycine site on the NMDA receptor.

  1994cited by this paper
• Excitatory amino acid antagonists and epilepsy.

  1993cited by this paper
• 3-Acyl-4-hydroxyquinolin-2(1H)-ones. Systemically active anticonvulsants acting by antagonism at the glycine site of the N-methyl-D-aspartate receptor complex.

  1993cited by this paper
• The glycine site of the NMDA receptor--five years on.

  1993cited by this paper
• 3-Nitro-3,4-dihydro-2(1H)-quinolones. Excitatory amino acid antagonists acting at glycine-site NMDA and (RS)-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors.

  1993cited by this paper
• Antiepileptogenic action of 7-chlorokynurenic acid on amygdala kindling of rats.

  1993cited by this paper
• 7-Chlorokynurenic acid antagonizes the anticonvulsant activity of D-cycloserine in maximal electroshock seizures.

  1992cited by this paper
• Potent indole- and quinoline-containing N-methyl-D-aspartate antagonists acting at the strychnine-insensitive glycine binding site.

  1992cited by this paper
• 3-Phenyl-4-hydroxyquinolin-2(1H)-ones: potent and selective antagonists at the strychnine-insensitive glycine site on the N-methyl-D-aspartate receptor complex.

  1992cited by this paper
• The glycine-site NMDA receptor antagonist, R-(+)-cis-beta-methyl-3-amino-1-hydroxypyrrolid-2-one, L-687,414 is anticonvulsant in baboons.

  1992cited by this paper
• Weak anticonvulsant activity of CGP 37849 and CGP 39551 against kindled seizures following systemic administration.

  1992cited by this paper
• The influence of strychnine-insensitive glycine receptor agonists and antagonists on generalized seizure thresholds.

  1991cited by this paper
• Effects of competitive and noncompetitive NMDA receptor antagonists on kindling and LTP.

  1991cited by this paper
• Anticonvulsant activity of the NMDA antagonists, D(-)4-(3-phosphonopropyl) piperazine-2-carboxylic acid (D-CPP) and D(-)(E)-4-(3-phosphonoprop-2-enyl) piperazine-2-carboxylic acid (D-CPPene) in a rodent and a primate model of reflex epilepsy.

  1990cited by this paper
• Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine.

  1990cited by this paper
• 7-Chlorokynurenic acid, a strychnine-insensitive glycine receptor antagonist, inhibits limbic seizure kindling.

  1990cited by this paper
• Selective blockade of N-methyl-D-aspartate (NMDA)-induced convulsions by NMDA antagonists and putative glycine antagonists: relationship with phencyclidine-like behavioral effects.

  1990cited by this paper
• Blockade of N-methyl-D-aspartate induced convulsions by 1-aminocyclopropanecarboxylates.

  1989cited by this paper
• Modification of seizure activity by electrical stimulation. II. Motor seizure.

  1972cited by this paper
• A simplified method of evaluating dose-effect experiments.

  1948cited by this paper

• Anti-Epileptic Activity

  2016cites this paper
• An Overview: The biologically important quninoline derivatives

  2016cites this paper
• The role of group I metabotropic glutamate receptors in absence epilepsy

  2016cites this paper
• Synthesis of 3,4‐Disubstituted Quinolin‐2‐(1H)‐ones via Palladium‐Catalyzed Decarboxylative Arylation Reactions

  2013cites this paper
• Glutamatergic neurotransmission as molecular target of new anticonvulsants.

  2012cites this paper
• EFECTO DE LOS PRETRATAMIENTOS SOLOS Y COMBINADO DE PROBENECID Y KINURENINA SOBRE EL DAÑO OXIDATIVO EN UN MODELO EXPERIMENTAL DE LA

  2010cites this paper
• Development of N-[11C]methylamino 4-hydroxy-2(1H)-quinolone derivatives as PET radioligands for the glycine-binding site of NMDA receptors.

  2009cites this paper
• Difference in brain distributions of carbon 11-labeled 4-hydroxy-2(1H)-quinolones as PET radioligands for the glycine-binding site of the NMDA ion channel.

  2008cites this paper
• Oral administration of glycine and polyamine receptor antagonists blocks ethanol withdrawal seizures

  2008cites this paper
• Synthesis, structural determination and photo-antiproliferative activity of new 3-pyrazolyl or -isoxazolyl substituted 4-hydroxy-2(1H)-quinolinones

  2006cites this paper
• Modulation of NMDA receptors by glycine — introduction to some basic aspects and recent developments

  2005cites this paper
• Antagonists and agonists at the glycine site of the NMDA receptor for therapeutic interventions.

  2003cites this paper
• Endogenous kynurenines as targets for drug discovery and development

  2002cites this paper
• Non-Lethal Swimmer Neutralization Study

  2002cites this paper
• Stone.vp:CorelVentura 7.0

  2001cites this paper
• Rapid microwave-enhanced synthesis of 4-hydroxyquinolinones under solvent-free conditions

  2001cites this paper
• Kynurenines in the CNS: from endogenous obscurity to therapeutic importance.

  2001cites this paper
• Inhibitors of the kynurenine pathway.

  2000cites this paper
• The role of probenecid-sensitive organic acid transport in the pharmacokinetics of N-methyl-D-aspartate receptor antagonists acting at the glycine(B)-site: microdialysis and maximum electroshock seizures studies.

  1999cites this paper
• Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications.

  1998cites this paper
• Glutamate in CNS disorders as a target for drug development: an update.

  1998cites this paper
• Pharmacology of glutamate receptor antagonists in the kindling model of epilepsy.

  1998cites this paper
• Glutamate receptors in epilepsy.

  1998cites this paper
• Enzyme-catalyzed production of the neuroprotective NMDA receptor antagonist 7-chlorokynurenic acid in the rat brain in vivo.

  1997cites this paper
• Pharmacological characterization of MDL 105,519, an NMDA receptor glycine site antagonist.

  1997cites this paper
• Psychotropic and neurotropic activity

  1997cites this paper
• Novel systemically active antagonists of the glycine site of the N-methyl-D-aspartate receptor: electrophysiological, biochemical and behavioral characterization.

  1997cites this paper
• Free D-aspartate and D-serine in the mammalian brain and periphery.

  1997cites this paper
• [3H]MDL 105,519, a high-affinity radioligand for the N-methyl-D-aspartate receptor-associated glycine recognition site.

  1996cites this paper
• Altered expression of group I metabotropic glutamate receptors in the hippocampus of amygdala-kindled rats.

  1996cites this paper
• Oral administration of glycine and polyamine receptor antagonists blocks ethanol withdrawal seizures

  1996cites this paper
• Neurotransmission in Epilepsy

  1995cites this paper
• NMDA antagonists: antiepileptic-neuroprotective drugs with diversified neuropharmacological profiles.

  1995cites this paper
• Involvement of dopamine in pilocarpine induced limbic motor seizures in the rat.

  1995cites this paper